PRMT10 Antikörper (N-Term)
(1 reference)Kurzübersicht für PRMT10 Antikörper (N-Term) (ABIN2849525)
Target
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 39-68, N-Term
-
Aufreinigung
- This antibody is purified through a protein A column, followed by peptide affinity purification.
-
Immunogen
- This PRMT10 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 39-68 amino acids from the N-terminal region of human PRMT10.
-
Isotyp
- IgG
-
-
anti-Protein Arginine Methyltransferase 10 (PRMT10) (AA 39-68), (N-Term) antibody
PRMT10 Reaktivität: Human WB Wirt: Kaninchen Polyclonal RB26323 unconjugated
anti-Protein Arginine Methyltransferase 10 (PRMT10) (AA 1-50) antibodyPRMT10 Reaktivität: Human IP, IHC, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Protein Arginine Methyltransferase 10 (PRMT10) (AA 795-845) antibodyPRMT10 Reaktivität: Human, Ratte WB, IP, IHC, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Protein Arginine Methyltransferase 10 (PRMT10) (AA 39-68) antibodyPRMT10 Reaktivität: Human, Maus WB, ELISA Wirt: Kaninchen Polyclonal unconjugated
-
-
Applikationshinweise
- WB: 1:1000
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- PRMT10 Antibody (N-term) can be refrigerated at 2-8 °C for up to 6 months. For long term storage, keep at -20 °C.
-
Haltbarkeit
- 6 months
-
-
-
: "Protein arginine methyltransferase 10 is required for androgen-dependent proliferation of LNCaP prostate cancer cells." in: Bioscience, biotechnology, and biochemistry, Vol. 79, Issue 9, pp. 1430-7, (2015) (PubMed).
-
: "Protein arginine methyltransferase 10 is required for androgen-dependent proliferation of LNCaP prostate cancer cells." in: Bioscience, biotechnology, and biochemistry, Vol. 79, Issue 9, pp. 1430-7, (2015) (PubMed).
-
-
